Loading
·
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
The quarterly reports for this company are not available yet. Please check back later.
In the mean time, check out some related stocks.